EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC 4.0

Predictive Factors for Increased Bone Density Following Romosozumab Administration Based on Pre-Administration Blood Test Results

Akira Kuwabara iD, Kazuhide Inage iD, Masaomi Yamashita iD, Sumihisa Orita iD, Yawara Eguchi iD, Yasuhiro Shiga iD, Masahiro Inoue iD, Miyako Suzuki-Narita iD, Takahisa Hishiya iD, Takahito Arai iD, Noriyasu Toshi iD, Kohei Okuyama iD und 5 weitere

Yonsei Medical Journal · 2025

DOI: 10.3349/ymj.2023.0535 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Yonsei Medical Journal, 2025. Verfasst von Akira Kuwabara und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan. Hauptthemen laut MEDLINE: Bone Density, Osteoporosis, Antibodies, Monoclonal, Bone Density Conservation Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone DensityOsteoporosisAntibodies, MonoclonalBone Density Conservation AgentsHumansFemaleRetrospective StudiesMaleAgedMiddle AgedAbsorptiometry, PhotonAged, 80 and overLumbar Vertebrae

Stichwörter der Autor:innen

Romosozumabbone densityosteoporosispredictive factors

Substanzen

romosozumabAntibodies, MonoclonalBone Density Conservation Agents

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Department of Rehabilitation, JCHO Funabashi Central Hospital, Funabashi, Japan.
  • Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan. kazuhideinage@chiba-u.jp.
  • Department of Orthopaedic Surgery, JCHO Funabashi Central Hospital, Funabashi, Japan.
  • Center for Frontier Medical Engineering, Chiba University, Chiba, Japan.
  • Department of Bioenvironmental Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.

ORCID-Profile: Akira Kuwabara, Kazuhide Inage, Masaomi Yamashita, Sumihisa Orita, Yawara Eguchi, Yasuhiro Shiga, Masahiro Inoue, Miyako Suzuki-Narita, Takahisa Hishiya, Takahito Arai, Noriyasu Toshi, Kohei Okuyama, Soichiro Tokeshi, Susumu Tashiro, Shuhei Ohyama, Noritaka Suzuki, Seiji Ohtori

Zitieren

APA

Kuwabara, A., Inage, K., Yamashita, M., Orita, S., Eguchi, Y., Shiga, Y., Inoue, M., Suzuki-Narita, M., Hishiya, T., Arai, T., Toshi, N., Okuyama, K., Tokeshi, S., Tashiro, S., Ohyama, S., Suzuki, N., & Ohtori, S. (2025). Predictive Factors for Increased Bone Density Following Romosozumab Administration Based on Pre-Administration Blood Test Results. Yonsei Medical Journal. https://doi.org/10.3349/ymj.2023.0535

Vancouver

Kuwabara A, Inage K, Yamashita M, Orita S, Eguchi Y, Shiga Y, et al. Predictive Factors for Increased Bone Density Following Romosozumab Administration Based on Pre-Administration Blood Test Results. Yonsei Medical Journal. 2025. doi:10.3349/ymj.2023.0535

BibTeX
@article{Kuwabara2025,
  author = {Kuwabara, Akira and Inage, Kazuhide and Yamashita, Masaomi and Orita, Sumihisa and Eguchi, Yawara and Shiga, Yasuhiro and Inoue, Masahiro and Suzuki-Narita, Miyako and Hishiya, Takahisa and Arai, Takahito and Toshi, Noriyasu and Okuyama, Kohei and Tokeshi, Soichiro and Tashiro, Susumu and Ohyama, Shuhei and Suzuki, Noritaka and Ohtori, Seiji},
  title = {Predictive Factors for Increased Bone Density Following Romosozumab Administration Based on Pre-Administration Blood Test Results},
  journal = {Yonsei Medical Journal},
  year = {2025},
  doi = {10.3349/ymj.2023.0535}
}
Kostenlos starten →